Clinical Trial Update: Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

An open-label Phase 4 study evaluated whether adalimumab with methotrexate could reduce steroid use in active rheumatoid arthritis. The trial has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 4 | Status: TERMINATED